Therapeutic agents useful for treating pain

Details Therapeutic agents useful for treating pain Therapeutic agents useful for treating pain

2006-01-20

2009-08-11

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S193000

Reexamination Certificate

active

07572812

ABSTRACT:
Piperidine Compounds; compositions comprising a Piperidine Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperidine Compound are disclosed. In one embodiment, the Piperidine Compound has the formula:and pharmaceutically acceptable salts thereof, wherein Ar1, Ar2, X, R3, R4, and m are as disclosed herein.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4409229 (1983-10-01), Ong et al.
patent: 4797419 (1989-01-01), Moos et al.
patent: 4853384 (1989-08-01), Helsley et al.
patent: 5039680 (1991-08-01), Imperato et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5198459 (1993-03-01), Imperato et al.
patent: 5232934 (1993-08-01), Downs
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5556837 (1996-09-01), Nestler et al.
patent: 5556838 (1996-09-01), Mayer et al.
patent: 5574052 (1996-11-01), Rose et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5762925 (1998-06-01), Sagen
patent: 5891889 (1999-04-01), Anthony et al.
patent: 6136839 (2000-10-01), Isakson et al.
patent: 6204284 (2001-03-01), Beer et al.
patent: 6239267 (2001-05-01), Duckworth et al.
patent: 6248756 (2001-06-01), Anthony et al.
patent: 6335180 (2002-01-01), Julius et al.
patent: 6406908 (2002-06-01), McIntyre et al.
patent: 6455550 (2002-09-01), Chen et al.
patent: 2002/0019389 (2002-02-01), Kim et al.
patent: 2002/0045614 (2002-04-01), Becker et al.
patent: 2003/0013720 (2003-01-01), Hobbs et al.
patent: 2004/0030192 (2004-02-01), Ishihara et al.
patent: 2004/0220191 (2004-11-01), Schwink et al.
patent: 2004/0259912 (2004-12-01), Matsumoto et al.
patent: 2005/0009841 (2005-01-01), Zheng et al.
patent: 2005/0080095 (2005-04-01), Zheng et al.
patent: 2005/0277674 (2005-12-01), Hinze et al.
patent: 2006/0148844 (2006-07-01), Nakade et al.
patent: 3 440 141 (1986-05-01), None
patent: WO 97-28140 (1997-10-01), None
patent: WO 97-38665 (1997-10-01), None
patent: WO 98-31669 (1998-07-01), None
patent: WO 98-31677 (1998-07-01), None
patent: WO 99-37304 (1999-07-01), None
patent: WO 01-17965 (2001-03-01), None
patent: WO 01-21577 (2001-03-01), None
patent: WO 01/27107 (2001-04-01), None
patent: WO 01-27107 (2001-04-01), None
patent: WO 01-81333 (2001-11-01), None
patent: WO 01-96331 (2001-12-01), None
patent: WO 02-48098 (2002-06-01), None
patent: WO 03-029199 (2003-10-01), None
Anilkumar et al., “A simple and efficient Iodination of alcohols on polymer-supported triphenylphosphine,”Organic Process Research and Development6(2):190-1 (2002).
Barnett et al., “Synthesis of picenadol via metalloenamine alkylation methodology,”J. Org. Chem.54(20):4795-4800 (1989).
Bartho et al., “Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation,”Naunyn-Schmiedeberg's Archives Pharmacol.342:666-670 (1990).
Berkow et al., “Seizure Disorders,”The Merck Manual of Medical Information, pp. 345-350 (1997).
Berkow et al., “Stroke,”The Merck Manual of Medical Information, pp. 352-355 (1997).
Berkow et al., “Peptic Ulcer,”The Merck Manual of Medical Information496-500 (1997).
Berkow et al., “Irritable Bowel Syndrome,”The Merck Manual of Medical Information525-526 (1997).
Berkow et al., “Crohn's Disease,”The Merck Manual of Medical Information528-530 (1997).
Berkow et al., “Urinary Incontinence,”The Merck Manual of Medical Information631-634 (1997).
Bleicher et al., “New phenylfluorenyl based linkers for solid phase synthesis,”Tett. Lett.41(47): 9037-42 (2000).
Buchwald et al., “Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis,”Surgery88:507 (1980).
Cammack et al., “Synthesis of Ketobemidone Precursors via Phase-Transfer Catalysis,”J. Heterocycle Chem.23(1):73-75 (1986).
Cheng et al., “The sulfone linker in solid-phase synthesis: preparation of 3,5-disubstituted cyclopent-2-enones,”J. Org. Chem.67(13): 4387-91 (2002).
Chiamulera et al., “Reinforcing and Locomotor Stimulant Effects of Cocaine are Absent in mGluR5 Null Mutant Rice,”Nature Neurosci.4(9):873-874 (2001).
Cotarca et al., “Bis(trichloromethyl) carbonate in organic synthesis,”Synthesis: J. Synthetic Org. Chem.5:553-576 (1996).
Controlled Drug Bioavailability, Drug Product Design and Performance(Smolen and Ball eds., 1984).
Cooke, “Glycopyrrolate in Bladder Dysfunction,”SA Medical J.63:3 (1983).
D'Ambra et al., “Novel synthesis of piperidinecarboxamides via aryl isocyanate acylation of α-amino carbanions,”J. Org. Chem.54(23):5632-5 (1989).
D'Amour et al., “A Method for Determining Loss of Pain Sensation,”J. Pharmacol. Exp. Ther.72:74-79 (1941).
Di Marzo et al., “Endovanilloid Signaling in Pain,”Current Opinion in Neurobiology12:372-379 (2002).
Dogrul et al., “Peripheral and Spinal Antihyperalgesic Activity of SIB-1757, A Metabotropic Glutamate Receptor (mGluR5) Antagonist, in Experimental Neuropathic Pain in Rats,”Neurosci. Lett.292(2):115-118 (2000).
During et al., “Controlled Release of Dopamine from a Polymeric Brain Implant: In Vivo Characterization,”Ann. Neurol.25:351 (1989).
Eckert et al., “Triphosgene, a crystalline phosgene substitute,”Angew. Chem. Int. Ed. Engl.26:894 (1987).
Mouysset et al., “Phenylbenzothiazoles and calcium inhibiting activity,”Farmaco45(9):945-53 (1990).
Foley, “Pain,”Cecil Textbook of Medicine, pp. 100-107 (1996).
Fundytus et al., “Antisense Oligonucleotide Knockdown of mGluR1Alleviates Hyperalgesia and Allodynia Associated with Chronic Inflammation,”Pharmacol., Biochem.&Behavior73:401-410 (2002).
Fundytus et al., “In vivo Antinociceptive Activity of Anti-Rat mGluR1and mGluR5Antibodies in Rats,”NeuroReport9: 731-735 (1998).
Fundytus et al., “Knockdown of Spinal Metabotropic Glutamate Receptor 1 (mGluR1) Alleviates Pain and Restores Opioid Efficacy after Nerve Injury in Rats,”Brit. J. Pharmacol.132:354-367 (2001).
Fundytus, “Glutamate Receptors and Nociception Implications for the Drug-Treatment of Pain,”CNS Drugs15:29-58 (2001).
Goodson, inMedical Applications of Controlled Release, vol. 2, pp. 115-138 (1984).
Greene et al.,Protective Groups in Organic Synthesis17-200 (3d ed. 1999).
Greene et al.,Protective Groups in Organic Synthesis494-653 (3d ed. 1999).
Grupp et al., “Protection against Hypoxia-reoxygenation in the Absence of Poly (ADP-ribose) Synthetase in Isolated Working Hearts,”J. Mol. Cell Cardiol.31:297-303 (1999).
Hallot et al., “Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazies in animal models of epilepsy,”J. Med. Chem.29(3):369-75 (1986).
Hanson, “Analgesic, Antipyretic and Anti-Inflammatory Drugs,”Remington: The Science and Practice of Pharmacyvol. II 1196-1221 (A.R. Gennaro ed. 19th ed. 1995).
Hargreaves et al., “A New and Sensitive Method for Measuring Thermal Noiception in

Affiliated with

Also associated with

Rating

Therapeutic agents useful for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agents useful for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents useful for treating pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4103807